No high-quality clinical trials have specifically investigated microdosing as a therapeutic strategy
Both treatment approaches resulted in a mean weight loss at 52 weeks, with oral semaglutide treatment resulting in a mean weight loss from baseline of 3.8 kg and 4.7 kg in the treatment-policy estimand and trial-product estimand analyses, respectively
Eli Lillys tirzepatide (the active ingredient in Zepbound and Mounjaro) mixes GLP-1 with the hormone GIP, for instance
In the initial multicenter, double-blind placebo-controlled randomized trial (the GOLDEN-505 trial), elafibranor at 80 mg and 120 mg were compared against placebo for treatment of NASH for 52 weeks
This connection activates G-proteins, increasing cyclic Adenosine Monophosphate (cAMP) levels (Campbell and Drucker 2013)
Well work with you to adjust it based on your experience and goals